@AimLoASCVD

AIM-LO is a guidelines-driven initiative for Canadian specialists to screen and optimize the Tx of high-risk patients with dyslipidemia whose LDL-C ≥1.8 mmol/L.

[@AimLoASCVD @AimLoASCVD]

90% of enrolled cardiologists confirm that AIM-LO reports are easily accessible, with unanimous agreement on the applicability of their recommendations. AIM-LO proves to be a valuable tool in managing patients with dyslipidemia and evaluating adherence to the CCS guidelines. https://t.co/gbfjXqfPjq #DoYouAimLo?

[@AimLoASCVD @AimLoASCVD]

Evaluate your adherence to the 2021 CCS Dyslipidemia Guidelines with AIM-LO. 105+ cardiologists across Canada, including Dr. Manian, have joined this unique QI initiative around dyslipidemia management. Participate today: https://t.co/j35ZjMBl1n. #DoYouAimLo?

[@AimLoASCVD @AimLoASCVD]

105 Canadian cardiologists have enrolled in AIM-LO, a quality improvement initiative around dyslipidemia, leveraging data held in their EMR. Join them and be part of the change that leads to better patient outcomes in dyslipidemia management. #DoYouAimLo?

[@AimLoASCVD @AimLoASCVD]

💓 Our initiative empowers specialists to identify high-risk patients whose LDL-C exceed the threshold recommended in the guidelines despite use of statins. Together, we're closing gaps between guidelines and practice, without adding admnistrative burden. Join AIM-LO at https://t.co/gbfjXqfPjq and make a real impact. #DoyouAimLo?

[@AimLoASCVD @AimLoASCVD]

We launched AIM-LO in July 2023 and early findings are in! Learn more about the criteria for screening high-risk patients and how this QI program was conceptualized with cardiologists and patients in mind: https://t.co/vf4bXOWN6o #DoYouAimLo?

[@AimLoASCVD @AimLoASCVD]

#DoYouAimLo?

Join the AIM-LO Movement Today! Visit https://t.co/gbfjXqfPjq to learn more.

60 Canadian cardiologists have signed up in the past 8 weeks and enrolment continues!

AIM-LO (ASCVD Identification and Management of Lipid-Lowering Therapy) is a medical practice assessment (MPA) initiative that is available to Canadian specialists including cardiologists, endocrinologists, and internists.

AIM-LO is your opportunity to take your practice to the next level. By aligning with evidence-based dyslipidemia management guidelines, you can provide the best possible care to your patients and enhance their cardiovascular health.

#DoYouAimLo Visit https://t.co/PjqKGkMVpT to sign-up.